Delivery Order SPE2DB20D3103-SPE2DB23FP1W8

Award Date 7/31/23
Potential Completion Date 8/1/23
Potential Value $14
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $59,520 delivery order to Amerisourcebergen Drug Corporation for 4561851810 OFLOXACIN 0.3% EYE DROPS 5ML. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and will provide the specified pharmaceutical product to DLA from Amerisourcebergen's facilities in Conshohocken, Pennsylvania. Performance is required from August 17-18, 2023. As a major provider of medical supplies and equipment to the U.S. military...
The Defense Logistics Agency awarded a $13,910 delivery order to Amerisourcebergen Drug Corporation for 4561655299 ! OFLOXACIN 0.3% EYE DROPS 5ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to the Defense Logistics Agency. Performance is required from July 31, 2023 through August 1, 2023 under a firm fixed price contract type. No subcontractors or set...
The Defense Logistics Agency awarded a $193,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561847660 units of ofloxacin 0.3% eye drops in 5mL bottles. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is August 17-18, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for a generic antibiotic eye drop supports the DLA's mission to provide...
The Defense Logistics Agency awarded a $166,920 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OFLOXACIN 0.3% eye drops. The single day contract has a period of performance from August 3 to August 4, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. As a major component of the Department of Defense supply chain, the DLA supports military readiness by procuring and delivering medical supplies and pharmaceuticals to armed forces...
The Defense Logistics Agency awarded a $84,960 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561291566 units of ofloxacin 0.3% eye drops in 5mL bottles. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order is to be completed between June 20-21, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports military treatment facilities and is responsible for...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $41,730 to Amerisourcebergen Drug Corporation for the supply of 4561919010 OFLOXACIN 0.3% EYE DROPS 5ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a one-day period of performance from August 23 to August 24, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics...
The Defense Logistics Agency awarded a $166,920 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OFLOXACIN 0.5% eye drops. The order is being fulfilled under the prime contractor's Corporate Office Division operations in Conshohocken, Pennsylvania, with all products required to be delivered by July 31, 2023. No additional details were provided regarding subcontractors or the DLA's programs and requirements necessitating this pharmaceutical supply. The award utilizes...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $22.32 to Amerisourcebergen Drug Corp for the supply of 4562315290 ! OFLOXACIN 0.3% EYE DROPS 5ML. The order was placed under an existing DLA contract vehicle and will be fulfilled by Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, operating from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The order has a period of performance...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $13,910 to Amerisourcebergen Drug Corporation for 4561910129 OFLOXACIN 0.3% EYE DROPS 5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is for ofloxacin ophthalmic solution, an antibiotic eye drop medication, and runs from August 23 to August 24, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the...
The Defense Logistics Agency awarded a $104,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561544830 units of 0.3% ofloxacin eye drops in 5mL bottles. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order has a period of performance from July 19, 2023 through July 20, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United States...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP1W8
    Delivery Order

The Defense Logistics Agency awarded a $13,910 delivery order to Amerisourcebergen Drug Corporation for 4561655270 OFLOXACIN 0.3% EYE DROPS 5ML. The firm fixed price order is under the DLA's pharmaceuticals contract vehicle and will provide the specified eye drops to support DOD programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 31 to August 1, 2023. No set aside designation or subcontractors were identified. This order continues DLA's practice of leveraging its pharmaceutical contracts to efficiently procure necessary medical supplies for the military.

Generated 12/23/23, 4:13 AM